- 27 February 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 95 (4) , 595-602
Abstract
Background Early noninvasive markers that identify patients at risk of renal allograft loss may stratify patients for more intensive monitoring or therapy. CCL2 is a CCR2 receptor chemokine that is a chemoattractant protein for monocytes/macrophages, T cells, and natural killer cells. We have previously demonstrated in a multicenter cohort that urinary CCL2 at 6 months is an independent predictor for the development of IFTA at 24 months. The goal of this study was to determine if early urinary CCL2 is a predictor of graft loss in an independent patient cohort. Methods A prospective, observational cohort study was conducted in the Transplant Manitoba Adult Kidney Program (n=231 patients) from 1997 to 2008. Six-month urinary CCL2 was measured by ELISA, corrected for urinary creatinine, and correlated with long-term graft outcomes. Results Urine CCL2: Cr at 6 months was significantly associated with death-censored graft loss (HR, 2.42; 95% CI, 1.54–3.82, PP=0.01) after adjustment for pretransplant/de novo donor-specific antibody and delayed graft function. An early posttransplant (≤6 months) multivariate model of CCL2, recipient age, and delayed graft function yielded an AUC 0.87 for prediction of death-censored graft loss. A cutoff value of urinary CCL2: Cr 34.8 ng/mmol yielded a strong positive predictive value of 0.96. Conclusions This study confirms in an independent prospective cohort that early urinary CCL2 at 6 months is a noninvasive, independent predictor for late renal allograft loss.Keywords
This publication has 36 references indexed in Scilit:
- Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and NonadherenceAmerican Journal of Transplantation, 2011
- Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and MortalityJournal of the American Society of Nephrology, 2011
- The Histology of Solitary Renal Allografts at 1 and 5 Years After TransplantationAmerican Journal of Transplantation, 2011
- Urinary Expression of Kidney Injury Markers in Renal Transplant RecipientsClinical Journal of the American Society of Nephrology, 2010
- Pathological and Clinical Characterization of the ‘Troubled Transplant’: Data from the DeKAF StudyAmerican Journal of Transplantation, 2010
- Factors Associated With Progression of Interstitial Fibrosis in Renal Transplant Patients Receiving Tacrolimus and Mycophenolate MofetilTransplantation, 2009
- The Utility of 1- and 3-Month Protocol Biopsies on Renal Allograft Function: A Randomized Controlled StudyAmerican Journal of Transplantation, 2008
- Lack of Benefit of Early Protocol Biopsies in Renal Transplant Patients Receiving TAC and MMF: A Randomized StudyAmerican Journal of Transplantation, 2007
- Patient Survival Following Renal Transplant Failure in CanadaAmerican Journal of Transplantation, 2005
- Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3European Journal of Immunology, 1994